BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 19785798)

  • 1. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease].
    Hovens MM; Cannegieter SC
    Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2097; author reply 2097-8. PubMed ID: 15532335
    [No Abstract]   [Full Text] [Related]  

  • 6. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.
    Bruno A; Grassi G; Dani F; Degiovanni M; Maghenzani G; Pagano G
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):42-6. PubMed ID: 15871850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
    Waltering A; Hemkens L; Florack C
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aspirin for primary prevention of cardiovascular diseases in diabetic patients: focus on gender difference and insulin resistance].
    Legrand DA; Scheen AJ
    Rev Med Liege; 2006 Oct; 61(10):682-90. PubMed ID: 17209500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Should we treat all diabetic patients with aspirin in primary prevention?].
    Righetti A; De Moerloose P; Philippe J
    Rev Med Suisse; 2005 Jun; 1(22):1500-4. PubMed ID: 16025889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin as primary prevention for diabetic patients].
    Fumeaux D; Becerra ME; Philippe J; Louis-Simonet M
    Rev Med Suisse; 2010 Feb; 6(234):244-8. PubMed ID: 20334083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin use in patients with diabetes mellitus].
    Sicras Mainar A; Ruiz Riera R; Frías Garrido X; Navarro Artieda R
    Med Clin (Barc); 2004 Jul; 123(6):237; author reply 239. PubMed ID: 15282081
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
    Welin L; Wilhelmsen L; Björnberg A; Odén A
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1143-9. PubMed ID: 19672841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.
    Bulatova NR; Yousef AM; AbuRuz SM
    Thromb Res; 2007; 121(1):43-50. PubMed ID: 17462716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of aspirin in diabetic patients].
    Türkoğlu S; Abaci A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.